SPA4 peptide attenuates the accumulation of selected damage-associated molecules and pulmonary cellularity during acute Pseudomonas aeruginosa infection in mice
- 1Department of Pharmaceutical Sciences, University of Oklahoma Health CampusOklahoma City, Oklahoma, United States of America
Abstract
Activation of Toll-like receptor 4 (TLR4) and accumulation of damage-associated molecular patterns (DAMPs) are hallmarks of infection and inflammation. The SPA4 peptide (amino acid sequence: GDFRYSDGTPVNYTNWYRGE) modulates TLR4-dependent host defense against Pseudomonas aeruginosa. In this study, we investigated the expression of TLR4, major DAMPs, and cellularity in the lungs of P. aeruginosa-infected mice treated with SPA4 peptide or vehicle. The expression of TLR4 and levels of DAMPs were analyzed by immunoblotting and enzyme-linked immunosorbent assay, respectively. Cellularity was determined in hematoxylin and eosin-stained lung tissue sections by microscopy. Our results demonstrated that the expression of TLR4 and DAMPs, as well as tissue cellularity, were increased in the lungs of infected mice. While P. aeruginosa-induced TLR4 expression was not affected, the levels of DAMPs were reduced in mice therapeutically treated with SPA4 peptide (fibrinogen: 8,730 ng; fibronectin: 17,925 ng; High Mobility Group Box-1 [HMGB-1]: 11,758 ng; and hyaluronan: 34,157 ng per g lung weight) compared with vehicle-treated mice (fibrinogen: 13,178 ng; fibronectin: 22,348 ng; HMGB-1: 15,896 ng; and hyaluronan: 53,644 ng per g lung weight). Correspondingly, reduced cellularity was noted in the lungs of SPA4 peptide-treated mice. These results advance our understanding of the SPA4 peptide activity against infectious stimuli.
Related
- Bacteriophage and Antibiotic Resistance Are Positively Associated across a Phylogenetically Diverse Set of Clinical Pseudomonas aeruginosa Isolates
- Host immune stress reveals a role for potassium homeostasis in Pseudomonas aeruginosa aggregate stability
- LytM family endopeptidase LmdC is controlled by regulated auto processing and proteolytic destruction in Pseudomonas aeruginosa
- Mining the Pseudomonas aeruginosa genome for regulators of type III secretion system gene expression using FT-Tn-seq
- Auranofin shows bactericidal activity in Pseudomonas aeruginosa by targeting thiol homeostasis
BibTeX
@article{awasthi2026spa4,
title = {{SPA4 peptide attenuates the accumulation of selected damage-associated molecules and pulmonary cellularity during acute Pseudomonas aeruginosa infection in mice}},
author = {Shanjana Awasthi and Bhupinder Singh and Jun Xie},
journal = {PLOS One},
year = {2026},
month = nov,
doi = {10.1371/journal.pone.0362301},
url = {https://doi.org/10.1371/journal.pone.0362301},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - SPA4 peptide attenuates the accumulation of selected damage-associated molecules and pulmonary cellularity during acute Pseudomonas aeruginosa infection in mice
AU - Shanjana Awasthi
AU - Bhupinder Singh
AU - Jun Xie
PY - 2026
DA - 2026/11/11
JO - PLOS One
DO - 10.1371/journal.pone.0362301
UR - https://doi.org/10.1371/journal.pone.0362301
AB - Activation of Toll-like receptor 4 (TLR4) and accumulation of damage-associated molecular patterns (DAMPs) are hallmarks of infection and inflammation. The SPA4 peptide (amino acid sequence: GDFRYSDGTPVNYTNWYRGE) modulates TLR4-dependent host defense against Pseudomonas aeruginosa. In this study, we investigated the expression of TLR4, major DAMPs, and cellularity in the lungs of P. aeruginosa-infected mice treated with SPA4 peptide or vehicle. The expression of TLR4 and levels of DAMPs were analyzed by immunoblotting and enzyme-linked immunosorbent assay, respectively. Cellularity was determined in hematoxylin and eosin-stained lung tissue sections by microscopy. Our results demonstrated that the expression of TLR4 and DAMPs, as well as tissue cellularity, were increased in the lungs of infected mice. While P. aeruginosa-induced TLR4 expression was not affected, the levels of DAMPs were reduced in mice therapeutically treated with SPA4 peptide (fibrinogen: 8,730 ng; fibronectin: 17,925 ng; High Mobility Group Box-1 [HMGB-1]: 11,758 ng; and hyaluronan: 34,157 ng per g lung weight) compared with vehicle-treated mice (fibrinogen: 13,178 ng; fibronectin: 22,348 ng; HMGB-1: 15,896 ng; and hyaluronan: 53,644 ng per g lung weight). Correspondingly, reduced cellularity was noted in the lungs of SPA4 peptide-treated mice. These results advance our understanding of the SPA4 peptide activity against infectious stimuli.
SN - 1932-6203
ER -